BIOVIE INC (BIVI) Forecast, Price Target & Analyst Ratings
NASDAQ:BIVI • US09074F5044
1.3426 USD
-0.03 (-2%)
Last: Mar 4, 2026, 09:58 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOVIE INC (BIVI).
Forecast Snapshot
Consensus Price Target
$12.24
+ 811.66% Upside
Next Earnings Forecast
Release DateMay 11, 2026
PeriodQ3 / 2026
EPS Estimate-$0.74
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$12.24
Upside
+ 811.66%
From current price of $1.34 to mean target of $12.24, Based on 7 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
-80.00%
Price Target Summary
7 analysts have analysed BIVI and the average price target is 12.24 USD. This implies a price increase of 811.66% is expected in the next year compared to the current price of 1.3426.
The average price target has been revised downward by 80% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
BIVI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BIVI.
In the previous month the buy percentage consensus was at a similar level.
BIVI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-07-01 | ThinkEquity | Initiate | Buy |
| 2023-11-30 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-17 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-02-14 | Oppenheimer | Reiterate | Outperform |
| 2022-09-28 | EF Hutton | Maintains | Buy |
| 2022-07-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-11-30 | B. Riley Securities | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 11, 2026
PeriodQ3 / 2026
EPS Estimate-$0.74
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-396.40%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
BIVI is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.74 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -100.00% | N/A | N/A | N/A | N/A 126.49% | ||||||||||||
| EBITDA YoY % growth | N/A | -380K | -1.32M -247.37% | -2.14M -62.12% | -2.27M -6.07% | -2.46M -8.37% | -137.82M -5,502.44% | -27.02M 80.39% | -44.85M -65.99% | -31.955M 28.75% | -17.369M 45.65% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -230K | -430K -86.96% | -1.55M -260.47% | -2.37M -52.90% | -2.5M -5.49% | -2.69M -7.60% | -138.05M -5,031.97% | -27.25M 80.26% | -45.08M -65.43% | -32.185M 28.61% | -17.598M 45.32% | N/A -26.70% | N/A 148.34% | N/A -349.82% | N/A -120.08% | N/A 37.35% | N/A 117.31% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 84.35% | -156.00 -36.10% | N/A 22.85% | N/A 96.26% | N/A 33.11% | N/A 246.78% | N/A 192.38% | N/A 106.24% | N/A 44.66% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.74 -396.40% | -0.53 -271.43% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -6.069M -95.19% | -4.406M -27.72% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
69.51%
EPS Next 5 Year
60.24%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOVIE INC / BIVI Forecast FAQ
What is the price target for BIVI stock?
7 analysts have analysed BIVI and the average price target is 12.24 USD. This implies a price increase of 811.66% is expected in the next year compared to the current price of 1.3426.
Can you provide the upcoming earnings date for BIOVIE INC?
BIOVIE INC (BIVI) will report earnings on 2026-05-11.
What are the consensus estimates for BIOVIE INC (BIVI) next earnings?
The consensus EPS estimate for the next earnings of BIOVIE INC (BIVI) is -0.74 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for BIVI stock?
The consensus rating for BIOVIE INC (BIVI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.